Biotechnology - Legal, Patents


Current filters:


Popular Filters

BioTime's subsidiary Asterias settles patent interference proceedings with ViaCyte


US biotech firm BioTime says its subsidiary Asterias Biotherapeutics has entered into a settlement agreement…

Asterias BiotherapeuticsBiotechnologyBioTimeLegalPatentsUSAViaCyte

Proposed new bill would create new patent term extension for certain biologics patents in USA

Proposed new bill would create new patent term extension for certain biologics patents in USA


Earlier this week in the USA, legislation was introduced allowing new sponsors to gain intellectual property…

BiotechnologyLegalNorth AmericaPatentsPoliticsUSA

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir

Idenix Pharma files law suits against Gilead in Europe over sofosbuvir


US drugmaker Idenix Pharmaceuticals says it has filed patent infringement law suits against biotech firm…

Anti-viralsBiotechnologyGilead SciencesIdenix PharmaceuticalsLegalNorthern EuropePatentssofosbuvirSovaldi

Amarin files suit against AstraZeneca over Epanova

Amarin files suit against AstraZeneca over Epanova


US biotech firm Amarin revealed in a Stock Exchange Commission submission that it has filed a complaint…

AmarinAstraZenecaBiotechnologyCardio-vascularEpanovaLegalNorth AmericaOmthera PharmaceuticalsPatentsUSAVascepa

USA’s BIO expresses serious concerns on Innovation Act, HR 3309


The US trade group Biotechnology Industry Organization (BIO) has expressed grave concerns relating to…

BiotechnologyLegalNorth AmericaPatentsPolitics

US Court denies re-hearing of Arzerra patent case


Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

US Supreme Court issues mixed ruling on DNA patents


The US Supreme Court yesterday (June 13) delivered its unanimous decision regarding the Association for…

BiotechnologyGeneticsLegalMyriad GeneticsNorth AmericaPatents

Cyclacel sells four disputed romidepsin-related patents to Celgene


USA based Cyclacel Pharmaceuticals (Nasdaq: CYCC) says that it has entered into a definitive agreement…

BiotechnologyCelgeneCyclacel PharmaceuticalsLegalOncologyPatentsromidepsin

European Parliament approves unitary patent rules


Following the historic vote yesterday in the European Union Parliament to approve the unitary patent…


"New" CDER Exclusivity Board focuses on clarity and consistency of exclusivity decisions


The US Food and Drug Administration recently announced that the agency has established within the Center…

BiotechnologyLegalNorth AmericaPatentsPharmaceuticalRegulation

GSK settles with Genentech over ofatumumab patents


UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

New IP legislation will encourage medical research in Australia, says trade group


New legislation overhauling the Australian patent system will encourage medical research and bring Australia…


Intellect Neurosciences appeals European patent decision


US neuro drug discovery firm Intellect Neurosciences (OTCBB: ILNS) says that it has filed an appeal regarding…

bapineuzumabBiotechnologyElanIntellect NeuroscienceLegalNeurologicalPatentsPfizerPharmaceutical

US court rules in GlaxoSmithKline’s favor in Arzerra patent dispute


A US District Court has entered final judgment in favor of UK pharma giant GlaxoSmithKline (LSE: GSK)…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceuticalRoche

Important decision for the biotech industry from UK Supreme Court


The UK’s Supreme Court yesterday gave guidance on the patentability of gene sequence inventions,…

BenlystaBiotechnologyEli LillyEuropeGlaxoSmithKlineHuman Genome SciencesLegalPatentsPharmaceutical

Company Spotlight



Back to top